Independent Director · BIOMARIN PHARMACEUTICAL INC (BMRN)

Athena Countouriotis, M.D director compensation at Biomarin: $494K

Fiscal year 2025 director compensation for Athena Countouriotis, M.D at BIOMARIN PHARMACEUTICAL INC. Every figure below is printed as the company filed it and cited to the filing it came from.

Director compensation as of the proxy filed April 21, 2026 (DEF 14A). Open the filing on EDGAR.

Free

Get Athena Countouriotis, M.D’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Also free: The Pay Desk, the weekly executive pay briefing.

Or track Athena Countouriotis, M.D and every company like it: Velarion Intel, free for 3 days, no card →

What they were paid

BIOMARIN PHARMACEUTICAL Director Compensation Table · all 3 fiscal years held
In US dollars, as BIOMARIN PHARMACEUTICAL reports it. Most recent year first. Totals are the company’s disclosed totals.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2025$95,125$398,535$0$0$493,660
FY2024$80,000$365,045—$0$445,045
FY2023$0$213,378——$213,378

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: BIOMARIN PHARMACEUTICAL INC DEF 14A filed April 21, 2026, accession 0001628280-26-026290, and prior-year filings. Open the filing on EDGAR.

How this page was built: the BIOMARIN PHARMACEUTICAL INC filed document, accession 0001628280-26-026290. Every figure is read from that document and cited to the page and table it appears in. Filed April 21, 2026.

Get the BIOMARIN PHARMACEUTICAL Board Governance Report

$493,660 Athena Countouriotis, M.D, FY2025 total director compensation

$500

The free page is the headline figures. The board report is director pay, board composition and committee fees combined into the same kind of document.

Data as of April 21, 2026 · Source: Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).

How this board is paid

company policy · FY2025

BIOMARIN PHARMACEUTICAL pays directors a $80,000 cash retainer and $400,000 in RSUs.

Committees

FY2025 · as the proxy prints them

Audit · CGN · Science and Technology

The rest of the BIOMARIN PHARMACEUTICAL board

FY2025 · as the company reported each
DirectorRoleFY2025 total
Alexander HardyDirector—
Barbara W. BodemIndependent Director$487,035
Elizabeth McKee AndersonIndependent Director$505,035
Ian T. ClarkIndependent Director$451,230
Mark J. EnyedyIndependent Director$501,285
Maykin Ho, Ph.DIndependent Director$502,785
Richard A. MeierChair of the Board$570,035
Robert J. HombachIndependent Director$509,535
Timothy P. WalbertIndependent Director$492,785
Willard Dere, M.DIndependent Director$509,035

The full BIOMARIN PHARMACEUTICAL compensation record

free company brief

This page is one director within BIOMARIN PHARMACEUTICAL's record. The company brief lists every named executive and director, each linking to their own page.

Peer companies

named in the BIOMARIN PHARMACEUTICAL proxy · each links to its own free brief

Order BMRN

Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.

Receipt, invoice, and report delivery. Guest checkout, no account required, secure payment by Stripe.

Board Governance Report